Long-term lymphocytic leukemia (CLL) is often a lymphoid malignancy characterised because of the proliferation and accumulation of experienced CD5+ B cells while in the blood, bone marrow and lymphoid tissues. The prognosis of CLL requires the presence of ≥5 x109/L mono - clonal B cells of standa